Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoimmunity's next top models.
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Development of oral immunomodulatory agents in the management of multiple sclerosis.
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
Low testosterone is associated with disability in men with multiple sclerosis.
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
The origin and application of experimental autoimmune encephalomyelitis.
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
Defining the clinical course of multiple sclerosis: The 2013 revisions.
Teriflunomide for multiple sclerosis.
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
USPTO list of patent term extensions
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model.

Pages